Authors
Latest:
What Do Pharmaceuticals Really Cost in the Long Run?This study found that brand price at launch and generic entry overstates long-run average pharmaceutical costs, with and without accounting for medical cost offsets.
Latest:
Molecular Testing Patterns in Metastatic Non—Small Cell Lung CancerAssessment of the timing of histologic and molecular testing indicates that testing occurred prior to treatment initiation for most patients with metastatic non—small cell lung cancer.
Latest:
Closing the Personalized Medicine Information Gap: HER2 Test Documentation PracticeDespite universal access to HER2 testing in Ontario, variability in reporting by region and disease severity presents challenges for program evaluation and quality improvement initiatives.
Latest:
Reference-Based Pricing: An Evidence-Based Solution for Lab Services ShoppingReference-based pricing combined with employer education and an online shopping tool significantly improved members' utilization of lab services at or below the reference price
Latest:
Impact of Switching Analogue Insulin to Human Insulin in DiabetesConverting from analogue insulin to human insulin is associated with a clinical insignificant increase in glycated hemoglobin of 0.16% but with improved insulin adherence.
Latest:
Number of Manufacturers and Generic Drug Pricing From 2005 to 2017Regardless of the number of manufacturers, generic drug prices presented double-digit average increases from 2012 to 2015.
Latest:
Payer's Role in Care: Gatekeeper or Change Agent?The panel discussion for Session 3, "The Role of Health Plans and Payers in Patient Care," discussed the role of payers in revolutionizing the system to make it patient-centric.
Latest:
Identifying Chronic Kidney Disease Stage 3 With Excess Disease BurdenA high-risk cohort of beneficiaries with chronic kidney disease (CKD) stage 3 have a profile similar to patients with CKD stages 4 and 5, indicating potential benefit of earlier nephrology intervention.
Latest:
The Role of Nurse Practitioners in Primary HealthcareThe potential of nurse practitioners is not being fully realized in primary care medical practices. Consequently, cost and quality gains are not being achieved.
Latest:
VHA Pharmacy Use in Veterans With Medicare Drug CoverageGreater Medicare managed care benefit levels reduce both the likelihood and magnitude of Veterans Health Administration pharmacy use by Medicare dually enrolled veterans.
Latest:
Economic and Clinical Impact of Routine Weekend Catheterization ServicesWeekend cardiac catheterization availability for inpatients reduced length of stay and maintained quality of care (no excess hazard for weekend cases), but costs were similar.
Latest:
Hypertension Control in Ambulatory Care Patients With DiabetesThis paper explores hypertension control among patients with diabetes in a variety of ambulatory care settings. We also consider the role of sociodemographic factors.
Latest:
Implementation of EHR-Based Strategies to Improve Outpatient CAD CareWe examined the impact of electronic reminders followed by performance reports and financial incentives. Physicians responded more to reports and incentives than to reminders alone.
Latest:
Novel Multicancer Early Detection Technology––Potential Value to Employers and the WorkforceMulticancer early detection technology could help reduce cancer mortality compared to the current strategy of single-cancer screening tests.
Latest:
Improving Medication Understanding Among Latinos Through Illustrated Medication ListsA randomized controlled trial found that plain-language, illustrated medication lists improved medication understanding among Latinos.
